Literature DB >> 23484815

Humanized mice for the development and testing of human vaccines.

Caroline Aspord1, Chun I Yu, Jacques Banchereau, A Karolina Palucka.   

Abstract

Mouse models of human disease form a link between genetics and biology. However, mice and humans differ in many aspects of immune system biology. These differences might explain, in part, why many successful preclinical immunotherapy studies in mice turn out to be unsuccessful when used in clinical trials in humans. Pioneering studies in the late 1980s demonstrated the reconstitution of human lympho-hematopoietic cells in immunodeficient mice. Since this time, immunodeficient mice are being tested as hosts for human hematopoietic organs or cells in an effort to create an in vivo model of the complete human immune system. Such Humouse models could permit us to generate and test novel human vaccines.

Entities:  

Year:  2007        PMID: 23484815     DOI: 10.1517/17460441.2.7.949

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  3 in total

1.  History of the biomedical studies PhD program: a joint graduate program of the Baylor Health Care system and Baylor University.

Authors:  Christine R Morel; Joshua M Horton; Han Peng; Kangling Xu; Sushil K Batra; Jonathan P Miles; Robert R Kane
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

2.  Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.

Authors:  Caroline Aspord; Laetitia Tramcourt; Claire Leloup; Jean-Paul Molens; Marie-Therese Leccia; Julie Charles; Joel Plumas
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

3.  A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells.

Authors:  Caroline Aspord; Julie Charles; Marie-Therese Leccia; David Laurin; Marie-Jeanne Richard; Laurence Chaperot; Joel Plumas
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.